MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AFTER POST-TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE: IS IT TOO LATE?

被引：0
|
作者：
Au, Kin Pan [1 ]
Chok, Kenneth Siu Ho [1 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Peoples R China
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-18.26
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 50 条
  • [21] Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence
    Toso, Christian
    Mentha, Gilles
    Majno, Pietro
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 3 - 5
  • [22] Validating post-transplant hepatocellular carcinoma recurrence data in the UNOS database
    Samoylova, Mariya
    Dodge, Jennifer L.
    Vittinghoff, Eric
    Yao, Francis Y.
    Roberts, John P.
    HEPATOLOGY, 2013, 58 : 1034A - 1035A
  • [23] Post-transplant recurrence patterns after liver transplantation for hepatocellular carcinoma: an international multicenter study
    Claasen, M. P. A. W.
    Ivanics, T.
    Montalva, E.
    Citterio, D.
    Beumer, B. R.
    Dhote, A.
    Adam, R.
    Mazzaferro, V.
    IJzermans, J. N. M.
    Sapisochin, G.
    Polak, W. G.
    TRANSPLANTATION, 2023, 107 (09) : 51 - 51
  • [24] Mammalian Target of Rapamycin as a Novel Target in the Treatment of Hepatocellular Carcinoma
    Guo, Yu
    Liang, Xinjun
    Lu, Minqiang
    Weng, Taohua
    Liu, Yanyan
    Ye, Xiaoming
    HEPATO-GASTROENTEROLOGY, 2010, 57 (101) : 913 - 918
  • [25] Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
    Gomez-Martin, Carlos
    Bustamante, Javier
    Castroagudin, Javier F.
    Salcedo, Magdalena
    Garralda, Elena
    Testillano, Milagros
    Herrero, Ignacio
    Matilla, Ana
    Sangro, Bruno
    LIVER TRANSPLANTATION, 2012, 18 (01) : 45 - 52
  • [26] Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma
    Cheung, Siu Tim
    Fan, Sheung Tat
    Lee, Yuk Ting
    Chow, Jeremy P.
    Ng, Irene O.
    Fong, Daniel Y.
    Lo, Chung Mau
    TRANSPLANTATION, 2008, 85 (01) : 81 - 87
  • [27] An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma
    Cheng, Jian-Wen
    Shi, Ying-Hong
    Fan, Jia
    Huang, Xiao-Wu
    Qiu, Shuang-Jian
    Xiao, Yong-Sheng
    Wang, Zheng
    Dai, Zhi
    Tang, Zhao-You
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1445 - 1453
  • [28] Hepatobiliary and Pancreatic: Post-transplant recurrence of fibrolamellar hepatocellular carcinoma in lung and pancreas
    Nguyen, B. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 286 - 286
  • [29] Analysis of Hepatocellular Carcinoma Downstaging and Other Risk Factors for Post-Transplant Recurrence
    Au, Jennifer
    Dadabhai, Alia S.
    Rossi, Simona
    Lai, Yinzhi
    Wang, Shaogui
    Herrine, Steven K.
    Navarro, Victor J.
    Fenkel, Jonathan M.
    Yang, Hushan
    HEPATOLOGY, 2012, 56 : 511A - 512A
  • [30] A Prospective Multicenter Validation of Retreat for Post-Transplant Hepatocellular Carcinoma Recurrence Prediction
    Li, J.
    Tabrizian, P.
    Daher, D.
    Ajmera, V.
    Montalvan, E.
    Gutierrez, J. A.
    Zhou, K.
    Imdad, F.
    Delebecque, F.
    Garcia, N.
    Barrick, B.
    Wong, C.
    Nephew, L.
    Holden, J.
    Dave, S.
    Schnickel, G.
    Rich, N.
    Florman, S.
    Yao, F.
    Singal, A.
    Mehta, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S532 - S532
12345